{"id":"furalazine","rwe":[],"tags":[{"label":"furalazine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"panfuran","offLabel":[],"synonyms":["furatrizine","furalazine","nifuralazine","furalazin","panfuran"],"timeline":[],"approvals":[],"brandName":"Panfuran","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"furalazine","explanation":"Think of it like a key that unlocks a specific process in the body. When this process is working properly, it helps the body function correctly. However, when it's not working right, it can lead to problems, and Furalazine may help fix that.","oneSentence":"Furalazine is believed to work by modulating cellular responses.","technicalDetail":"Furalazine is a small molecule that interacts with cellular targets, potentially influencing gene expression and signaling pathways to exert its effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/70","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FURALAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:39:34.359725","biosimilars":[],"competitors":[],"genericName":"furalazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"2133JVQ6VE","CHEBI":"CHEBI:135137","INN_ID":"1415","UMLSCUI":"C0603287","ChEMBL_ID":"CHEMBL2106765","KEGG_DRUG":"D02511","PUBCHEM_CID":"6436102","SECONDARY_CAS_RN":"556-12-7","MESH_SUPPLEMENTAL_RECORD_UI":"C007794"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Panfuran, also known as Furalazine, is a small molecule drug in the furalazine class. Its exact target and mechanism of action are unknown, but it is believed to work by modulating cellular responses. Furalazine is not FDA-approved for any indications, and its commercial status, patent status, and availability of generic manufacturers are also unknown. As a result, there is limited information available on its safety profile and efficacy. Further research is needed to fully understand the properties and potential uses of Furalazine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}